Menu
Back to Journals » Vascular Health and Risk Management » Volume 16
Review
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,908 | Dovepress* | 5,031+ | 1,293 | 6,324 | |
| PubMed Central* | 877 | 304 | 1,181 | ||
| Totals | 5,908 | 1,597 | 7,505 | ||
| *Since 7 October 2020 | |||||
View citations on PubMed Central and Google Scholar